Innovision IPO Allotment Status: Check on KFinTech, BSE, NSE

Innovision IPO allotment is to be finalised today, 18 March 2026. The issue had a slow start, then the company extended the IPO till 17 March and cut the price band to ₹494–₹519 to revive demand. That move worked partly, with a late surge from institutional and HNI investors.

In this blog, you will see how to check your Innovision IPO allotment status on BSE, NSE, and the registrar KFin Technologies. You will also get a quick view of the final subscription numbers, the GMP trend, and what the extension, price cut, and current sentiment together could mean for listing.

Important Dates

• Allotment date: 18 March 2026
• Refund initiation: 19 March 2026
• Demat credit of shares: 19 March 2026
• Listing date: 20 March 2026

How to Check Innovision IPO Allotment Status

Method 1: Check on BSE

• Open the BSE IPO allotment page: https://www.bseindia.com/investors/appli_check.aspx
• Choose “Equity” as the issue type.
• Select “Innovision Ltd” from the dropdown list.
• Enter your application number or PAN, and the captcha code.
• Click “Search” to see whether shares have been allotted to you.

Method 2: Check on NSE

• Go to the NSE IPO allotment status page: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
• Click on “Equity & SME IPO bid details.”
• Select “Innovision Ltd” from the issue name list.
• Enter your application number or PAN.
• Submit to view if you have received shares or not.

Method 3: Check on KFin Technologies (Registrar)

• Visit KFin Technologies’ IPO issues page: https://ipostatus.kfintech.com
• Choose “Innovision Ltd” from the dropdown list.
• Select the search option: PAN, DP ID/Client ID, or Application Number.
• Click “Submit” to see your detailed allotment status.

Innovision IPO Subscription Details

Source: Chittorgarh

• The issue was very quiet in the first three days, and only after the extension and price cut did demand shoot up on Day 5 and Day 6, mostly from QIBs and HNIs.
• For retail investors, a 0.6x subscription means a relatively higher chance of full allotment if you applied, because the retail bucket did not even fully fill.
• Heavy oversubscription in QIB and NII means allotment in these categories will be tight, and many HNI applicants will either get a very small allocation or none at all.

Also Read: Innovision IPO Extended Till March 17, Cuts Price: Check GMP, Subscription, Updated Valuation

Innovision IPO GMP Update

The grey market premium, or GMP, was flat at ₹0 just before opening and on Day 1, jumped to about ₹66 on Day 2, then cooled off again. It turned slightly positive around the middle of the issue and finally moved into negative territory, at about -₹35 on allotment day, implying a possible listing discount of nearly 6.74%.

Overall, sentiment swung from neutral to hopeful and then back to cautious, even after the extension and price cut, which tells you that the market is still not fully convinced at the current risk-reward.

Disclaimer: GMP is an unofficial indicator and is subject to market volatility.

What’s Next After Allotment?

If shares are allotted

• Your allotted shares will show up on the BSE / NSE / KFin allotment status page against your application details.
• These shares should get credited to your demat account by 19 March 2026.
• If you applied for more lots and got fewer, the extra amount will be refunded or your UPI mandate will be released for the unallotted portion.
• Next, keep an eye on the listing price and early trading action, especially because this IPO needed an extension and a price cut plus is coming into the market with a weak to negative GMP.

If shares are not allotted

• You will see “No allotment” or zero shares on the status page, and your full application amount should be refunded or your UPI mandate released, typically by 19 March 2026.
• If you still like the company after listing, you can consider buying from the secondary market once the stock starts trading and the price stabilises.
• In IPOs where select categories are heavily oversubscribed, and where terms are changed mid-way, like extension and price cuts, it is common for many applicants, especially HNIs, to miss out on allotment.

For detailed information, visit Innovision’s official IPO page at INDmoney.

Final Word

Innovision’s IPO story has been a bit unusual: a weak start, a last-minute extension, a price band cut, strong institutional demand at the end, but a soft retail response and a negative GMP into allotment. For listing, this mix points to a more cautious market mood, not a euphoric one.

If you are allotted shares, treat listing as just one data point and weigh the solid growth and returns against the client concentration, cash flow issues, and the fact that the IPO needed support through both more time and a lower price. If you are not allotted, you have the benefit of watching how the stock trades after listing before taking any fresh call.

For more IPOs, check INDmoney’s IPO tracker here.

Disclaimer

Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Please be informed that merely opening a trading and demat account will not guarantee investment in securities in the IPO. Investors are requested to do their own independent research and due diligence before investing in an IPO. Please read the SEBI-prescribed Combined Risk Disclosure Document prior to investing. This post is for general information and awareness purposes only and is nowhere to be considered as advice, recommendation, or solicitation of an offer to buy or sell, or subscribe for securities. INDstocks is acting as a distributor for non-broking products/services such as IPO, Mutual Fund, and Mutual Fund SIP. These are not exchange-traded products. All disputes with respect to the distribution activity would not have access to the Exchange investor redressal forum or the Arbitration mechanism. INDstocks Private Limited (formerly known as INDmoney Private Limited) does not provide any portfolio management services, nor is it an investment adviser. Logos above are the property of respective trademark owners, and by displaying them, INDstocks has no right, title, or interest in them. SEBI Stock Broking Registration No: INZ000305337, Trading and Clearing Member of NSE (90267, M70042) and BSE, BSE StarMF (6779), SEBI Depository Participant Reg. No. IN-DP-690-2022, Depository Participant ID: CDSL 12095500, Research Analyst Registration No. INH000018948 BSE RA Enlistment No. 6428.